Antibody signature of spontaneous clearance of Chlamydia trachomatis ocular infection and partial resistance against re-challenge in a nonhuman primate trachoma model.
Antibody signature of spontaneous clearance of Chlamydia trachomatis ocular infection and partial resistance against re-challenge in a nonhuman primate trachoma model.
复制标题
DOI:
10.1371/journal.pntd.0002248
复制
发表时间:
2013
影响因子:
3.8
通讯作者:
Caldwell HD
中科院分区:
文献类型:
--
作者:
Kari L;Bakios LE;Goheen MM;Bess LN;Watkins HS;Southern TR;Song L;Whitmire WM;Olivares-Zavaleta N;Caldwell HD
Chlamydia trachomatis is the etiological agent of trachoma the world's leading cause of infectious blindness. Here, we investigate whether protracted clearance of a primary infection in nonhuman primates is attributable to antigenic variation or related to the maturation of the anti-chlamydial humoral immune response specific to chlamydial antigens. Genomic sequencing of organisms isolated throughout the protracted primary infection revealed that antigenic variation was not related to the inability of monkeys to efficiently resolve their infection. To explore the maturation of the humoral immune response as a possible reason for delayed clearance, sera were analyzed by radioimmunoprecipitation using intrinsically radio-labeled antigens prepared under non-denaturing conditions. Antibody recognition was restricted to the antigenically variable major outer membrane protein (MOMP) and a few antigenically conserved antigens. Recognition of MOMP occurred early post-infection and correlated with reduction in infectious ocular burdens but not with infection eradication. In contrast, antibody recognition of conserved antigens, identified as PmpD, Hsp60, CPAF and Pgp3, appeared late and correlated with infection eradication. Partial immunity to re-challenge was associated with a discernible antibody recall response against all antigens. Antibody recognition of PmpD and CPAF was destroyed by heat treatment while MOMP and Pgp3 were partially affected, indicating that antibody specific to conformational epitopes on these proteins may be important to protective immunity. Our findings suggest that delayed clearance of chlamydial infection in NHP is not the result of antigenic variation but rather a consequence of the gradual maturation of the C. trachomatis antigen-specific humoral immune response. However, we cannot conclude that antibodies specific for these proteins play the primary role in host protective immunity as they could be surrogate markers of T cell immunity. Collectively, our results argue that an efficacious subunit trachoma vaccine might require a combination of these antigens delivered in their native conformation. Chlamydia trachomatis is the etiological agent of trachoma the world's leading cause of infectious blindness. In this study, we investigated whether delayed clearance of a primary infection in nonhuman primates was attributable to antigenic variation or related to gradual changes in the humoral immune response specific to chlamydial antigens. We found that antigenic variation was not related to the inability of monkeys to efficiently resolve their infection. However, exploring changes in the immune response as a possible reason for delayed clearance revealed that antibody recognition was restricted to the antigenically variable major surface protein and a few conserved polypeptides. Antibody recognition of the major antigenically variable surface protein correlated with the initial reduction in infectious burdens while recognition of conserved chlamydial antigens occurred late and correlated with infection eradication. These findings suggest that delayed clearance of chlamydial infection is not the result of antigenic variation but a consequence of a gradually evolving humoral immune response specific to different chlamydial antigens. Antibody recognition was at least partially directed against conformational epitopes, indicating that an efficacious subunit trachoma vaccine might require a combination of antigens delivered in their native conformation.
登录
查看更多内容
影响因子:
3.1
作者:
Murthy, Ashlesh K.;Chambers, James P.;Arulanandam, Bernard P.
通讯作者:
Arulanandam, Bernard P.
DOI:
10.1084/jem.20111266
发表时间:
2011-10-24
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Kari L;Whitmire WM;Olivares-Zavaleta N;Goheen MM;Taylor LD;Carlson JH;Sturdevant GL;Lu C;Bakios LE;Randall LB;Parnell MJ;Zhong G;Caldwell HD
通讯作者:
Caldwell HD
影响因子:
3.1
作者:
COMANDUCCI, M;MANETTI, R;RATTI, G
通讯作者:
RATTI, G
影响因子:
158.5
作者:
SCHACHTER, J
通讯作者:
SCHACHTER, J
DOI:
10.4049/jimmunol.0804375
发表时间:
2009-06-15
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
Kari L;Whitmire WM;Crane DD;Reveneau N;Carlson JH;Goheen MM;Peterson EM;Pal S;de la Maza LM;Caldwell HD
通讯作者:
Caldwell HD